Creatine and N-acetylaspartate metabolism
Log in to starAmino acid metabolism
Last updated Nov 4, 2026
Log in to add personal notes on this page.
Creatine and N-acetylaspartate (NAA) are two small molecules built from amino acids that the brain holds in large amounts, and both show as peaks on proton MR spectroscopy. Creatine travels in blood to its main users, muscle and brain, and the creatine-phosphocreatine shuttle maintains the energy supply of skeletal and cardiac muscle. NAA is abundant in the brain, where its breakdown is thought to help maintain white matter. The disorders on this page are recognized by which peak is wrong: the creatine peak is absent or markedly reduced in the creatine disorders, and the NAA peak is raised in Canavan disease.
- arginine + glycine → guanidinoacetate (GAA): L-arginine:glycine amidinotransferase, AGAT (GATM), mainly in kidney and pancreas. It moves the amidino group of arginine onto glycine.
- GAA → creatine: guanidinoacetate methyltransferase, GAMT (GAMT), mainly in liver, using S-adenosylmethionine as the methyl donor.
- Creatine in blood → creatine inside brain and muscle: the sodium- and chloride-dependent creatine transporter (SLC6A8). Muscle makes no creatine of its own and depends on this uptake. Steps 1 to 3 are blocked in the cerebral creatine deficiency syndromes.
- NAA → aspartate + acetate: aspartoacylase (ASPA). NAA is abundant in the brain. Blocked in Canavan disease.
- Cerebral creatine deficiency syndromes: brain creatine falls in all three, and developmental delay, intellectual disability, and a speech-language disorder are common to all.
- GAMT (autosomal recessive): creatine is not made and GAA builds up to neurotoxic levels; seizures occur in more than 70% and movement disorders in about 30%. Treatment adds ornithine and arginine or protein restriction to creatine, to lower GAA.
- GATM (autosomal recessive): synthesis never starts, so GAA is low.
- SLC6A8 (X-linked, the most common): creatine is made but cannot enter brain or muscle, so males have high urine creatine. Carrier females range from unaffected to mildly affected.
- Creatine started early can give normal development in the two synthesis defects.
- Canavan disease: NAA cannot be hydrolyzed. Its buildup in the brain causes demyelination: a leukodystrophy with progressive macrocephaly, and hypotonia that turns to spasticity. NAA is markedly raised in urine. Two Ashkenazi Jewish founder variants abolish activity; variants that keep some activity give the milder atypical form. Care is supportive.
- Proton MR spectroscopy reads both. An absent or markedly reduced creatine peak is found in GAMT deficiency, AGAT deficiency, and males with the transporter defect; carrier females can show a partial reduction or a normal peak. A raised NAA peak marks Canavan disease and can make the diagnosis even when urine and serum NAA are normal.
- Guanidinoacetate in plasma or urine separates the two synthesis defects: high in GAMT deficiency, because the second step is blocked, and low in AGAT deficiency, because the first step never makes it.
- The urine creatine-to-creatinine ratio is raised in males with the transporter defect, because creatine is made and then cannot be taken up; females can be normal, so sequencing identifies them.
- Urine NAA is markedly raised in typical Canavan disease and only about 10-fold raised in the atypical form.